Description
Cada frasco contiene 300 mg de ocrelizumab
FORMA FARMACÉUTICA: 1 SUSPENSION
Cada tableta contiene mirabegrón 50 mg
Monitoreo médico periódico
DOSIS: 4 MG
INVOKER 0.5MG/ML SOL FCO C/DOSIF FERRER THERAPEUTICS Cada frasco contiene 300 mgPRINCIPIO ACTIVO: LEVOCETIRIZINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
























